Rapid cognitive decline in Alzheimer's disease: A literature review

International Review of Psychiatry

Volumn 25, Issue 6, 2013, Pages 650-658

  Sona, Alessandro ^a   Ellis, Kathryn A ^b,c,d   Ames, David ^c,d  

^a UNIVERSITY OF TURIN   (Italy)

^b FLOREY INSTITUTE OF NEUROSCIENCE AND MENTAL HEALTH   (Australia)

^c ROYAL MELBOURNE HOSPITAL   (Australia)

^d UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; BRAIN DERIVED NEUROTROPHIC FACTOR; C REACTIVE PROTEIN; CHOLESTEROL;

ALLELE; ALZHEIMER DISEASE; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COGNITIVE DEFECT; DEMENTIA; DIABETES MELLITUS; DISEASE COURSE; EDUCATIONAL STATUS; FAMILY HISTORY; GENOTYPE; HEART ATRIUM FIBRILLATION; HUMAN; HYPERTENSION; MEDICAL LITERATURE; MEDLINE; MINI MENTAL STATE EXAMINATION; NEUROPSYCHOLOGICAL TEST; NURSING HOME; ONSET AGE; PRIORITY JOURNAL; PSYCINFO; PUBLICATION; REVIEW; RISK FACTOR; SEX DIFFERENCE; SMOKING;

AGE FACTORS; ALZHEIMER DISEASE; COGNITION DISORDERS; DISEASE PROGRESSION; HUMANS; NEUROPSYCHOLOGICAL TESTS; SEX FACTORS;

EID: 84892770082     PISSN: 09540261     EISSN: 13691627     Source Type: Journal    
DOI: 10.3109/09540261.2013.859128     Document Type: Review

References (90)

1. Abellan van Kan, G., Rolland, Y., Nourashemi, F., Coley, N., Andrieu, S. & Vellas, B., on behalf of the REAL.FR group. (2009). Cardiovascular risk factors and progression of Alzheimer's disease. Alzheimer Disease and Associated Disorders, 27, 240-246.
2. Adak S., Illouz, M., Gorman M., Tandon, R., Zimmerman, E., Guariglia, B., ... Kaye, J. (2004). Predicting the rate of cognitive decline in aging and early Alzheimer disease. Neurology, 63, 108-111.
3. AD International. (2009). World Alzheimer Report. London: Alzheimer's Disease International.
4. Aguero-Torres, H., Fratiglioni, L., Zhenchao, G., Viitanen, M. & Winblad, B. (1998). Prognostic factors in very old demented adults: A seven year follow up from a population-based survey in Stockholm. Journal of the American Geriatrics Society, 46, 444-452.
5. Alexander, G.E., Furey, M.L., Grady, C.L., Pietrini, P., Mentis, M.J. & Schapiro, M.B. (1997). Association of premorbid function with cerebral metabolism in Alzheimer's disease: Implications for the reserve hypothesis. American Journal of Psychiatry, 154, 165-172.
6. Allan, C.L. & Ebmeier, K.P. (2010). The influence of ApoE4 on clinical progression of dementia: A meta-analysis. International Journal of Geriatric Psychiatry, 25, 1-7.
7. Amieva, H., Jaqmin-Gadda, H., Orgogozo, J., Le Carret M., Helmer, C., Letteneur, L., ... Dartigues, J. (2005). The 9 year cognitive decline before dementia of the Alzheimer type: A prospective population-based study. Brain, 128, 1093-1101.
8. Anstey, K.J., von Sanden, C., Salim, A. & O'Kearney, R. (2007). Smoking as a risk factor for dementia and cognitive decline: A meta-analysis of prospective studies. American Journal of Epidemiology, 166, 367-378.
9. Backman, L., Jones, S., Small, B.J., Aguero-Torres, H. & Fratiglioni, L. (2003). Rate of cognitive decline in preclinical Alzheimer's disease: The role of comorbidity. Journal of Gerontology Psychological Sciences, 58B, 228-236.
10. Basun, H., Grut, M., Winblad, B. & Lannfelt, L. (1995). Apolipoprotein epsilon 4 allele and disease progression in patients with late-onset Alzheimer's disease. Neuroscience Letters, 183, 32-34.
11. Bellew, K.M., Pigeon, J.G., Stang, P.E., Fleischman, W., Gardner, R.M. & Baker, W.W. (2004). Hypertension and the rate of cognitive decline in patients with dementia of the Alzheimer type. Alzheimer Disease and Associated Disorders, 18, 208-213.
12. Berr, C., Wancata, J. & Ritchie, K. (2005). Prevalence of dementia in the elderly in Europe. European Neuropsychopharmacology, 15, 463-471.
13. Bhargava, D., Weiner, M.F., Hynan, L.S., Diaz-Arrastia, R. & Lipton, A.M. (2006). Vascular disease and risk factors, rate of progression, and survival in Alzheimer's disease. Journal of Geriatric Psychiatry and Neurology, 19, 78-82.
14. Bowler, J.V., Munoz, D.G., Merskey, H. & Hachinski, V. (1998). Factors affecting the age of onset and rate of progression of Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 65, 184-190.
15. Burns, A., Jacoby, R. & Levy, R. (1991). Progression of cognitive impairment in Alzheimer's disease. Journal of the American Geriatrics Society, 39, 39-45.
16. Capitani, E., Cazzaniga, R., Francescani, A. & Spinnler, H. (2004). Cognitive deterioration in Alzheimer's disease: Is the early course predictive of the later stages Neurological Sciences, 25, 198-204.
17. Carcaillon, L., Peres, K, Pere, J.J., Helmer, C., Orgogozo, J.M. & Dartigues, J.F. (2007). Fast cognitive decline at the time of dementia diagnosis: A major prognostic factor for survival in the community. Dementiua and Geriatric Cognitive Disorders, 24, 138-145.
18. Cortes, F., Gillette-Guyonnet, S., Nourashemi, F., Christelle, C. & Vellas, B. (2006). Family history of dementia does not influence the progression of Alzheimer's disease at two years: Results from the REAL.FR study. American Journal of Alzheimer Disease and Other Dementias, 21, 131-136.
19. Cosentino S., Scarmeas, N., Helzner, E. Glymour, M., Brandt, J., Albert, M., ... Stern, Y. (2008). APOE epsilon 4 allele predicts faster cognitive decline in mild Alzheimer disease. Neurology, 70, 1842-1849.
20. Craft, S., Teri, L., Edland, S., Kukull, W., Schellenberg, G., McCormick, W., ... Larsen, E. (1998). Accelerated decline in apolipoprotein E-epsilon 4 homozygotes with Alzheimer's disease. Neurology, 51, 149-153.
21. Dal Forno, G., Rassmusson, G., Brandt, J., Carson, K., Brookmeyer, R., Troconso, K. & Kawas, C. (1996). Apolipoprotein E genotype and rate of decline in probable Alzheimer's disease. Archives of Neurology, 53, 345-350.
22. Deschaintre, Y., Richard, F., Leys, D. & Pasquier, F. (2009). Treatment of vascular risk factors is associated with slower decline in Alzheimer disease. Neurology, 73, 674-680.
23. Doody, R.S., Massman, P. & Dunn, K. (2001). A method for estimating progression rates in Alzheimer's disease. Archives of Neurology, 58, 449-454.
24. Doody, R.S., Pavlik, V., Massman, P., Rountree, S., Darby, E. & Chan, W. (2010). Predicting progression of Alzheimer's disease. Alzheimer's Research and Therapy, 2, 2-9.
25. Evans, R.M., Hui, S., Perkins, A., Lahiri, D.K., Poirier, J. & Farlow, M.R. (2004). Cholesterol and APOE genotype interact to influence Alzheimer disease progression. Neurology, 62, 1869-1871.
26. Flicker, L. (2010). Screening and assessment instruments for the detection and measurement of cognitive impairment. In D. Ames, A. Burns, and J. O'Brien, (Eds), Dementia (4th ed.) (p. 57). London: Hodder Arnold.
27. Frisoni, G.B., Govoni, S., Goroldi, C., Bianchetti, A., Calabresi, L., Francheschini, G. & Trabucchi, M. (1995). Gene dose of the epsilon 4 allele of apolipoprotein E and disease progression in sporadic late-onset Alzheimer's disease. Annals of Neurology, 37, 596-604.
28. Frisoni, G.B., Henneman, W., Weiner, M., Scheltens, P., Vellas, B., Reynish, E. ... The Alzheimer's Disease Neuroimaging Initiative. (2008). The pilot European Alzheimer's Disease Neuroimaging Initiative of the European Alzheimer's Disease Consortium. Alzheimer's Dementia, 4, 255-264.
29. Fritsch, T., McClendon, M.J., Smyth, K.A. & Ogrocki, P.K. (2002). Effects of educational attainment and occupational status on cognitive and functional decline in persons with Alzheimertype dementia. International Psychogeriatrics, 14, 347-363.
30. Gomez-Isla, T., West, W., Rebeck, G., Harr, S., Growdon, J., Locasio, J., ... Hyman, B. (1996). Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Annals of Neurology, 39, 62-70.
31. Growdon, J.H., Locascio, J.J., Corkin, S., Gomez-Isla, T. & Hyman, B.T. (1996). Apolipoprotein E genotype does not influence rates of cognitive decline in Alzheimer's disease. Neurology, 47, 444-448.
32. Helzner, E.P., Luchsinger, J., Scarmeas, N., Cosentino, S., Brickman, A., Glymour, M. & Stern, Y. (2009). Contribution of vascular risk factors to the progression in alzheimer disease. Archives of Neurology, 66, 343-348.
33. Hirono, N., Hashimoto, M., Yasuda, M., Kazui, H. & Mori, E. (2003). Accelerated memory decline in Alzheimer's disease with apolipoprotein 4 allele. Journal of Neuropsychiatry and Clinical Neuroscience, 15, 354-358.
34. Ho, G.J., Hansen, L., Alford, M., Foster, K., Salmon, D., Galasko, D., ... Masliah, E. (2002). Age at onset is associated with disease severity in Lewy body variant and Alzheimer's disease. Neuroreport, 13, 1825-1828.
35. Holmes, C., Levy, R., McLoughlin, D.M., Powell, J.F. & Lovestone, S. (1996). Apolipoprotein E: Non-cognitive symptoms and cognitive decline in late onset Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 61, 580-583.
36. Holthouse, C. & Gubbay, S.S. (1997). Alzheimer's disease: Clinical predictors of rates of intellectual decline-A prospective study. Age and Ageing, 26, 407-410.
37. Holtzer, R., Wegesin, D., Albert, S., Marder, K., Bell, K., Albert, M., ... Stern, Y. (2003). The rate of cognitive decline and risk of reaching clinical milestones in Alzheimer's disease. Archives of Neurology, 60, 1137-1142.
38. Hoyt, B.D., Massman, P.J., Schatschneider, C., Cooke, N. & Doody, R.S. (2005). Individual growth curve analysis of APOE epsilon 4-associated cognitive decline in Alzheimer disease. Archives of Neurology, 62, 454-459.
39. Ito, K., Corrigan, B., Zhao, Q., French, J., Miller, R., Soares, H., ... Fullerton, T. (2010). Disease progression model for cognitive deterioration from Alzheimer's Disease Neuroimaging Initiative database. Alzheimer's and Dementia, 1, 10.
40. Jacobs, D., Sano, M., Marder, K., Bell, K., Bylsma, F., Lafleche, G., ... Stern, Y. (1990). Age at onset on Alzheimer's disease: Relation to pattern of cognitive dysfunction and rate of decline. Neurology, 40, 8-14.
41. Jonker, C., Schmand, B., Lindeboom, J., Havekes, L.M. & Launer, L.J. (1998). Association between apolipoprotein E epsilon4 and the rate of cognitive decline in communitydwelling elderly individuals with and without dementia. Archives of Neurology, 55, 1065-1069.
42. Katzman, R., Brown, T., Thal, L., Fuld, P., Aronson, M., Butters, N., ... Terry, R. (1988). Comparison of annual rate of change of mental status score in four independent studies of patients with Alzheimer's disease. Annals of Neurology, 24, 384-389.
43. Kim, J.M., Shin, I.S. & Yoon, J.S. (2002). Apolipoprotein E among Korean Alzheimer's disease patients in communitydwelling and hospitalized elderly samples. Dementia and Geriatric Cognitive Disorders, 13, 119-124.
44. Kleiman, T., Zdanys, K., Black, B., Rightmer, T., Grey, M., Garman, K ... van Dyck, C. (2006). Apolipoprotein E epsilon4 allele is unrelated to cognitive or functional decline in Alzheimer's disease: Retrospective and prospective analysis. Dementia and Geriatric Cognitive Disorders, 22, 73-82.
45. Kramer-Ginsberg, E., Mohs, R., Aryan, M., Lobel, D., Silverman, J., Davidson, M. & Davis, K. (1988). Clinical predictors of course for Alzheimer patients in a longitudinal study: A preliminary report. Psychopharmacology Bulletin, 24, 458-462.
46. Kurz, A., Egensperger, R., Haupt, M., Lautenschlager, N., Romero, B., Graebner, M. & Muller, U. (1996). Apolipoprotein E epsilon 4 allele, cognitive decline, and deterioration of everyday performance in Alzheimer's disease. Neurology, 47, 440-443.
47. Laske, C., Stellos, K., Hoffmann, N., Stransky, E., Straten, G., Eschweiler, G. & Leyhe, T. (2010). Higher BDNF serum levels predict slower cognitive decline in Alzheimer's disease patients. International Journal of Neuropsychopharmacolology, 22, 1-6.
48. Lee, J.H., Olichney, J., Hansen, L.A., Hofstetter, C.R. & Thal, L. (2007). Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Archives of Neurology, 57, 1474-1479.
49. Locascio, J.J., Fukumoto, H., Yap, L., Bottiglieri, T., Growdon, J., Hyman, B. & Irizarry, M. (2008). Plasma amyloid β-protein and C-reactive protein in relation to the rate of progression of Alzheimer disease. Archives of Neurology, 65, 776-785.
50. Lucca, U., Comelli, M., Tettamanti, M., Tiraboschi, P. & Spagnoli, A. (1993). Rate of progression and prognostic factors in Alzheimer's disease: A prospective study. Journal of the American Geriatrics Society, 41, 45-49.
51. Mann, U.M., Mohr, E. & Chase, T.N. (1989). Rapidly progressing Alzheimer's disease. Lancet, 2 (8666), 799.
52. Martins, C.A.L., Oulhaj, A., de Jager, C.A. & Williams, J.H. (2005). APOE alleles predict the rate of cognitive decline in Alzheimer disease. A non-linear model. Neurology, 65, 1888-1893.
53. Masse, I., Bordet, R., Deplanque, D., Al Khedr, A., Richard, F., Libersa, C. & Pasquier, F. (2005). Lipid lowering agents are associated with a slower cognitive decline in Alzheimer's disease. Journal of Neurology Neurosurgery and Psychiatry, 76, 1624-1629.
54. McGuinness, B., O'Hare, J., Craig, D., Bullock, R., Malouf, R. & Passmore, P. (2010). Statins for the treatment of dementia. Cochrane Database of Systems Review, 8, C D007514.
55. Mendiondo, M.S., Ashford, J.W., Kryscio, R.J. & Schmitt, F.A. (2000) Modeling Mini Mental State Examination changes in Alzheimer's disease. Statistical Medicine, 19, 1607-1616.
56. Mielke, M.M., Rosenberg, P., Tschanz, J., Cook, L., Corcoran C., Hayden, K., ... Lyketsos, C. (2007). Vascular factors predict rate of progression in Alzheimer disease. Neurology, 69, 1850-1858.
57. Morris, J.C., Edland, S., Clark, C., Galasko, Koss, E., Mohs, R., ... Heyman, A. (1993). The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part IV. Rates of cognitive change in the longitudinal assessment of probable Alzheimer's disease. Neurology, 43, 2457-2465.
58. Mungas, D., Reed, B.R., Ellis, W.G. & Jagust, W. (2001). The effects of age on rate of progression of Alzheimer disease and dementia with associated cerebrovascular disease. Archives of Neurology, 58, 1243-1247.
59. Murphy, G.M., Taylor, J., Kraemer, H.C., Yesavage, J. & Tinklenberg, J.R. (1997). No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease. American Journal of Psychiatry, 154, 603-608.
60. Musicco, M., Palmer, K., Salamone, G., Luppo, F., Perry, R., Mosti, S., ... Caltagirone, C. (2009). Predictors of progression of cognitive decline in Alzheimer's disease: The role of vascular and sociodemographic factors. Journal of Neurology, 256, 1288-1295.
61. Musicco, M., Salamone, G., Caltagirone, C., Cravello, L., Fadda, L., Lupo, F, ... Palmer, K. (2010). Neuropsychological predictors of rapidly progressing patients with Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 30, 219-228.
62. Neumann, P.J., Araki S., Arcelus, A., Longo, A., Papadopoulos, G., Kosic, K., ... Bhattacharya, A. (2001). Measuring Alzheimer's disease progression with transition probabilities. Estimates from CERAD. Neurology, 57, 957-964.
63. O'Hara, R., Thompson, J., Kraemer, H., Fenn, C., Taylor, J., Ross, L., ... Tinklenberg, J. (2002). Which Alzheimer patients are at risk for rapid cognitive decline Journal of Geriatric Psychiatry and Neurology, 15, 233-238.
64. Ortof, E. & Crystal, H.A. (1989). Rate of progression of Alzheimer's disease. Journal of the American Geriatrics Society, 37, 511-514.
65. Ousset, P.J., Nourhashemi, F., Reynish, E. & Vellas, B. (2008). Nutritional status is associated with disease progression in very mild Alzheimer disease. Alzheimer Disease and Associated Disorders, 22, 66-71.
66. Peters, R., Poulter, R., Warner, J., Beckett, N., Burch, L. & Bulpitt, C. (2008). Smoking, dementia and cognitive decline in the elderly, a systematic review. BMC Geriatrics, 8, 36.
67. Plastino, M., Fava, A., Pirritano, D., Cotronei, P., Sacco, N., Sperli, T., ... Bosco, D. (2009). Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. Journal of the Neurological Sciences, 288, 112-116.
68. Rasmusson, D.X., Carson, K.A., Brookmeyer, R., Kawas, C. & Brandt, J. (1996). Predicting rate of cognitive decline in probable Alzheimer's disease. Brain Cognition, 31, 133-147.
69. Regan, C., Katona, C., Walker, Z., Hooper, J., Donovan, J. & Livingstone, G. (2006). Relationship of vascular risk to the progression of Alzheimer disease. Neurology, 67, 1357-1362.
70. Roselli, F., Tartaglione, B., Federico, F., Lepore, V., Defazio, G. & Livrea, P. (2009). Rate of MMSE score change in Alzheimer's disease: Influence of education and vascular risk factors. Clinical Neurology and Neurosurgery, 111, 327-330.
71. Rosenstein, L.D. (1998). Differential diagnosis of the major progressive dementias and depression in middle and late adulthood: A summary of the literature of the early 1990s. Neuropshycological Reviews, 8, 109-167.
72. Sanz, C., Andrieu, S., Sinclair, A., Hanaire, H. & Vellas, B., for the REAL.FR Study Group. (2009). Diabetes is associated with a slower rate of cognitive decline in Alzheimer disease. Neurology, 73, 1359-1366.
73. Savva, G.M., Wharton, S.B., Ince, P.G., Forster, G., Matthews, F.E. & Brayne, C. (2009). Age, neuropathology and dementia. New England Journal of Medicine, 360, 2302-2309.
74. Scarmeas, N., Albert, S.M., Manly, J.J. & Stern, Y. (2006). Education and rate of cognitive decline in incident Alzheimer's disease. Journal of Neurology Neurosurgery Psychiatry, 77, 308-316.
75. Sheng, B., Cheng, L.F., Law, C.B., Li, H.L., Yeung, K.M. & Lau, K.K. (2007). Coexisting cerebral infarction in Alzheimer's disease is associated with fast dementia progression: Applying the National Institute for Neurological Disorders and Stroke/Association Internationale pour la Recherche et l'Enseignement en Neurosciences Neuroimaging criteria in Alzheimer's disease with concomitant cerebral infarction. Journal of the American Geriatrics Society, 55, 918-922.
76. Sluimer, J.D., Vrenken, H., Blankenstein, M., Fox, N., Scheltens, P., Barkhof, F. & van der Flier, W.M. (2008). Whole-brain atrophy rate in Alzheimer disease: Identifying fast progressors. Neurology, 70, 1836-1841.
77. Soto, M.E., Andrieu, S., Arbus, C., Ceccaldi, M., Couratier, P., Dantoine, T., ... Vellas, B. (2008a). Rapid cognitive decline in Alzheimer disease. Consensus paper. Journal of Nutrition Health and Aging, 12, 703-713.
78. Soto, M.E., Andrieu, S., Cantet, C., Reynish, E., Ousset, P., Arbus, C., ... REAL.FR group. (2008b). Predictive value of rapid decline in Mini Mental State Examination in clinical practice for prognosis in Alzheimer's disease. Dementia and Geriatric Cognitive Disorders, 26, 109-116.
79. Soto, M.E., Gillette-Guyonnet, S., Vellas, B. & the REAL.FR group. (2005). Rapid cognitive decline: Searching for a definition and predictive factor among elderly with Alzheimer's disease. Journal of Nutrition, Health and Aging, 9, 158-161.
80. Sparks, D.L., Sabbah, N., Connor, D., Lopez, J., Lowner, L., Browne, P., ... Ziolwoski, C. (2005). Atorvastatin for the treatment of mild to moderate Alzheimer disease. Preliminary results. Archives of Neurology, 62, 753-757.
81. Stern, R.G., Albert, M. & Mayeux, R. (1994). A longitudinal study of Alzheimer's disease: Measurement, rate and predictors of cognitive deterioration. American Journal of Psychiatry, 151, 390-396.
82. Stern, Y., Alexander, G.E., Prohovnik, I. & Mayew, R. (1992). Inverse relationship between education and parietotemporal perfusion deficit in Alzheimer's disease. Annals of Neurology, 32, 371-375.
83. Stern, Y., Albert, S., Tang, M.X. & Tsai, W.Y. (1999). Rate of memory decline in AD is related to education and occupation: Cognitive reserve Neurology, 53, 1942-1947.
84. Stern, Y., Brandt J. Albert, M. Jacobs, D., Liu, X., Bell, K., ... Mayeux, R. (1997). The absence of an apolipoprotein epsilon4 allele is associated with a more aggressive form of Alzheimer's disease. Annals of Neurology, 41, 615-620.
85. Storandt, M., Grant, E.A., Miller, J.P. & Morris. J.C. (2002). Rates of progression in mild cognitive impairment and early Alzheimer disease. Neurology, 59, 1034-1041.
86. Suh, G.H., Ju, Y.S., Yeon, B.K. & Shah, A. (2004). A longitudinal study of Alzheimer's disease: Rates of cognitive and functional decline. International Journal of Geriatric Psychiatry, 19, 817-824.
87. Swanwick, G.R.J., Coen, R.F., Coakley, D. & Lawlor, B.A. (1998). Assessment of progression and prognosis in ' possible'and ' probable'Alzheimer's disease. International Journal of Geriatric Psychiatry, 13, 331-335.
88. Teri, L., McCurry, S.M., Edland, S.D., Kukull, W.A. & Larson, E.B. (1995). Cognitive decline in Alzheimer's disease: A longitudinal investigation of risk factors for accelerated decline. Journal of Gerontology Series A: Biological Sciences and Medical Sciences, 50, M49-M55.
89. Wilson, R.S., Li, Y., Aggarwal, N., Barnes L., McCann, A., Gilley D. & Evans D. (2004). Education and the course of cognitive decline in Alzheimer disease. Neurology, 63, 1198-1202.
90. Wilson, R.S., McCann, J.J., Li, Y., Aggarwal, N.T., Gilley, D.V. & Evans, D.A. (2007). Nursing home placement, day care use, and cognitive decline in Alzheimer's disease. American Journal of Psychiatry, 164, 910-916.